PY-MAA-VAL-CIT-PAB-MMAE
UNII VFG8L8V3G5

Substance Identification & Data

This profile provides standardized clinical and technical data for Py-maa-val-cit-pab-mmae, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VFG8L8V3G5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2247398-68-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VFG8L8V3G5

CAS Registry Number

2247398-68-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PY-MAA-VAL-CIT-PAB-MMAE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C72H111N13O16S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ASDXMJBJAKMFHO-NGASZDMPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

146572802

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H]([C@H](C(N[C@@H]([C@@H](O)c1ccccc1)C)=O)C)([C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(OCc3ccc(NC([C@@H](NC([C@@H](NC(CSCCC(=O)N4CN(C(C=C)=O)CN(C(C=C)=O)C4)=O)C(C)C)=O)CCCNC(N)=O)=O)cc3)=O)C)C(C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H])OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Py-maa-val-cit-pab-mmae. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

PY-MAA-VAL-CIT-PAB-MMAE

ZAPADCINE-3A

Systematic Nomenclature

L-VALINAMIDE, N-METHYL-N-(((4-((N-(2-((3-OXO-3-(TETRAHYDRO-3,5-BIS(1-OXO-2-PROPEN-1-YL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)THIO)ACETYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-3-PHENYLPROPYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-

SYS

N-METHYL-N-(((4-((N-(2-((3-OXO-3-(TETRAHYDRO-3,5-BIS(1-OXO-2-PROPEN-1-YL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)THIO)ACETYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-3-PHENYLPROPYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

SYS

External Clinical & Regulatory Resources

Previous UNIIVFG7H7L4GQ

Next UNIIVFH398C4TK